Sheri Kashmir Institute of Medical Sciences (SKIMS) Job Notification: Sheri Kashmir Institute of Medical Sciences (SKIMS) has invited applications for the Project Technical Officer, Junior Nurse and Data Entry Operator posts. Interested candidates can apply for Sheri Kashmir Institute of Medical Sciences (SKIMS) Recruitment 2020 through the prescribed format on or before 22 February 2020.
Important Date:
- Closing Date for submission of Offline Application: 22 February 2020
Sheri Kashmir Institute of Medical Sciences (SKIMS) Project Technical Officer, Junior Nurse and Data Entry Operator Vacancy Details
- Project Technical Officer: 01 Post
- Junior Nurse/Field Worker: 04 Posts
- Data Entry Operator: 01 Post
Also Read: Top 5 Govt. Jobs of the Day–14 February 2020
Eligibility Criteria for Project Technical Officer, Junior Nurse and Data Entry Operator Job
Educational Qualification:
- Project Technical Officer: Graduation in Science/relevant subjects from a recognized university with two-year research experience in the relevant field, or Master’s degree in life sciences/
- statistics/social sciences/or allied from a recognized university.
- Junior Nurse/Field Worker: 10+2 in Science subjects with any additional qualification in medical field.
- Data Entry Operator: Graduation in Computer Science from recognized university or Master’s degree in relevant subject from a recognized university.
| Official Notification Download Here | |
| Official Website Link |
Download our Sarkari Naukri app from Play Store
How to Apply
Interested candidates can apply for Sheri Kashmir Institute of Medical Sciences (SKIMS) Recruitment 2020 through the prescribed format on or before 22 February 2020. Applications as per the attached format with the self-attested copies of certificates/documents should reach the office of the undersigned, or of Chief Medical Officer Kargil, up to 22 February 2020. No application form shall be entertained beyond 22 February 2020. Application form without complete documents will not be entertained.
Comments
All Comments (0)
Join the conversation